Suven Life Science will be presenting several exciting new results and data presentations from its portfolio of investigational neuroscience new chemical entities (NCEs) at Alzheimer's Association International Conference (AAIC) being held in Boston, USA during July 13-18, 2013.
AAIC is the world’s largest conference of its kind, bringing together researchers from around the world to report and discuss groundbreaking research and information on the cause, diagnosis, treatment and prevention of Alzheimer’s disease and related disorders.
The company has excellent portfolio of new molecules through four mechanisms of action using 5-HT6, 5-HT4, and H3 and Neuronal Nicotinic acetylcholine receptors for the treatment of cognitive impairment in Alzheimer’s disease symptomatically but also possibly useful in reducing the disease progression.
| Company Name | CMP |
|---|---|
| Sun Pharma Inds. | 1675.20 |
| Dr. Reddys Lab | 1235.40 |
| Cipla | 1238.30 |
| Zydus Lifesciences | 942.55 |
| Lupin | 2324.25 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: